4D Molecular Therapeutics Inc - FDMT - stock price prediction, stock price target, analyst ratings from 12 analysts

4D Molecular Therapeutics Inc has a share price target of US$ 31, revenue growth forecast of 11825.0%, and profit growth estimate of -22.8% for FY25, based on top 12 analyst calls.